TNFRSF21/DR6 Rekombinanter Antikörper
TNFRSF21/DR6 Rekombinant Antikörper für FC
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
FC
Konjugation
Unkonjugiert
CloneNo.
250249D8
Kat-Nr. : 98523-2-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
98523-2-PBS bindet in FC TNFRSF21/DR6 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | TNFRSF21/DR6 fusion protein Eg2718 |
| Vollständiger Name | tumor necrosis factor receptor superfamily, member 21 |
| Berechnetes Molekulargewicht | 72 kDa |
| GenBank-Zugangsnummer | NM_014452.5 |
| Gene symbol | DR6 |
| Gene ID (NCBI) | 27242 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. |
Hintergrundinformationen
TNFRSF21 (also known as DR6 or CD358) is an orphan receptor of the tumor necrosis factor (TNF) receptor superfamily. It controls cell death and differentiation in a cell-autonomous manner in different cell types including neurons, oligodendrocytes, endothelial cells, and immune cells (PMID: 29459438). DR6 has been shown to activate NF-κB and JNK, and induce cell apoptosis (PMID: 9714541). DR6 interacts with TRADD, which is known to mediate signal transduction of TNF receptors. It has been reported that APP binds DR6 to trigger axon pruning and neuron death via distinct caspases, indicating that DR6 might be involved in Alzheimer's disease (PMID: 19225519).







